ResearcherHoward Hughes Medical InstituteActive in the last 2 years
Surojit Sur
Matched on ORCID iD 0000-0003-4536-7343; OpenAlex author ID A5027552704. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 19
2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers
Papers 4
- ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1. Last author DOI 10.7554/elife.94488↗
- ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1 Last author DOI 10.7554/elife.94488.3↗
- Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer. First author DOI 10.1158/1078-0432.ccr-14-1271↗
- Genetically defined subsets of human pancreatic cancer show unique in vitro chemosensitivity. Co-author DOI 10.1158/1078-0432.ccr-12-0827↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Bert Vogelstein · 4 shared papers, 2012–2025 · strength 0.47
- Paper ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxyl… DOI 10.7554/elife.94488↗
- Paper ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxyl… DOI 10.7554/elife.94488.3↗
- Paper Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer. DOI 10.1158/1078-0432.ccr-14-1271↗
- Kenneth W. Kinzler · 3 shared papers, 2012–2025 · strength 0.44
- Paper ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxyl… DOI 10.7554/elife.94488↗
- Paper ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxyl… DOI 10.7554/elife.94488.3↗
- Paper Genetically defined subsets of human pancreatic cancer show unique in vitro chemosensitivity. DOI 10.1158/1078-0432.ccr-12-0827↗
- Nickolas Papadopoulos · 2 shared papers, 2025 · strength 0.41
- Paper ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxyl… DOI 10.7554/elife.94488↗
- Paper ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxyl… DOI 10.7554/elife.94488.3↗
- Marco Dal Molin · 2 shared papers, 2025 · strength 0.41
- Paper ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxyl… DOI 10.7554/elife.94488↗
- Paper ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxyl… DOI 10.7554/elife.94488.3↗
- Jordina Rincón-Torroella · 2 shared papers, 2025 · strength 0.41
- Paper ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxyl… DOI 10.7554/elife.94488↗
- Paper ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxyl… DOI 10.7554/elife.94488.3↗
- Nilofer Saba Azad · 2 shared papers, 2025 · strength 0.41
- Paper ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxyl… DOI 10.7554/elife.94488↗
- Paper ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxyl… DOI 10.7554/elife.94488.3↗
- Phuoc Tho Tran · 1 shared paper, 2014 · strength 0.03
- Jean-François H. Geschwind · 1 shared paper, 2014 · strength 0.03
- Shanmugasundaram Ganapathy‐Kanniappan · 1 shared paper, 2014 · strength 0.03
- Julius Chapiro · 1 shared paper, 2014 · strength 0.03
- Joseph M. Herman · 1 shared paper, 2014 · strength 0.03
- Rafael Durán · 1 shared paper, 2014 · strength 0.03
- Yunfeng Cui · 1 shared paper, 2012 · strength 0.03
- Amanda L. Blackford · 1 shared paper, 2012 · strength 0.03
- James R. Eshleman · 1 shared paper, 2012 · strength 0.03
- Anirban Maitra · 1 shared paper, 2012 · strength 0.03
- Christine A. Iacobuzio–Donahue · 1 shared paper, 2012 · strength 0.03
- Ralph H. Hruban MD · 1 shared paper, 2012 · strength 0.03
- Luis Alberto Diaz · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.